Severe Hemophilia A Without Inhibitor Clinical Trials
2 recruiting trials for Severe Hemophilia A Without Inhibitor. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Severe Hemophilia A Without Inhibitor clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Tri-Service General Hospital (1), Christoph Königs (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is serum biomarker. (diagnostic_test, 1 trial), followed by no interventions.
Track Severe Hemophilia A Without Inhibitor trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia...
Study Objectives\* 1. Provide a systematic evaluation of the treatment outcomes in patients with hemophilia A 2. Emphasize the importance and clinical benefits of rFVIII-Fc in...
Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
The goal of this observational study is to learn about the changes of antibodies and inhibitors against the coagulation factor VIII in patients with severe hemophilia A receiving...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Severe Hemophilia A Without Inhibitor, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Severe Hemophilia A Without Inhibitor, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Severe Hemophilia A Without Inhibitor, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.